1. Home
  2. SMTI vs OCEAW Comparison

SMTI vs OCEAW Comparison

Compare SMTI & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTI
  • OCEAW
  • Stock Information
  • Founded
  • SMTI 1982
  • OCEAW N/A
  • Country
  • SMTI United States
  • OCEAW United States
  • Employees
  • SMTI N/A
  • OCEAW 7
  • Industry
  • SMTI Medical/Dental Instruments
  • OCEAW Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMTI Health Care
  • OCEAW Health Care
  • Exchange
  • SMTI Nasdaq
  • OCEAW Nasdaq
  • Market Cap
  • SMTI 266.7M
  • OCEAW N/A
  • IPO Year
  • SMTI N/A
  • OCEAW 2021
  • Fundamental
  • Price
  • SMTI $29.43
  • OCEAW $0.02
  • Analyst Decision
  • SMTI Strong Buy
  • OCEAW
  • Analyst Count
  • SMTI 2
  • OCEAW 0
  • Target Price
  • SMTI $48.50
  • OCEAW N/A
  • AVG Volume (30 Days)
  • SMTI 38.6K
  • OCEAW N/A
  • Earning Date
  • SMTI 05-12-2025
  • OCEAW N/A
  • Dividend Yield
  • SMTI N/A
  • OCEAW N/A
  • EPS Growth
  • SMTI N/A
  • OCEAW N/A
  • EPS
  • SMTI N/A
  • OCEAW N/A
  • Revenue
  • SMTI $86,672,425.00
  • OCEAW N/A
  • Revenue This Year
  • SMTI $23.68
  • OCEAW N/A
  • Revenue Next Year
  • SMTI $5.80
  • OCEAW N/A
  • P/E Ratio
  • SMTI N/A
  • OCEAW N/A
  • Revenue Growth
  • SMTI 33.36
  • OCEAW N/A
  • 52 Week Low
  • SMTI $25.86
  • OCEAW N/A
  • 52 Week High
  • SMTI $39.08
  • OCEAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SMTI 45.66
  • OCEAW N/A
  • Support Level
  • SMTI $27.36
  • OCEAW N/A
  • Resistance Level
  • SMTI $30.37
  • OCEAW N/A
  • Average True Range (ATR)
  • SMTI 2.00
  • OCEAW 0.00
  • MACD
  • SMTI 0.13
  • OCEAW 0.00
  • Stochastic Oscillator
  • SMTI 67.36
  • OCEAW 0.00

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

About OCEAW Ocean Biomediacal Inc.

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

Share on Social Networks: